与自身免疫相关的发作疾病
Kelsey M Smith1, Adrian Budhram2,3, Christian Geis4
1Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
概括
由于神经自身抗体,人们越来越多地认识到自免疫性发作的原因. 早期诊断和免疫治疗至关重要,特别是针对细胞表面抗原的自身免疫脑炎.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
背景情况:
- 随着神经自身抗体的发现,人们越来越多地认识到的自身免疫病因.
- 特定的自身抗体与不同的临床表型相关,有助于更早的诊断.
研究的目的:
- 审查自身免疫机制在症中不断扩大的作用.
- 突出识别和治疗自身免疫相关发作的重要性,包括新发炎性状态 (NORSE) 和发烧性感染相关综合征 (FIRES).
主要方法:
- 对与特定神经自身抗体相关的临床表型的审查.
- 基于抗体点 (细胞表面与细胞内抗原) 和疾病机制 (例如拉斯穆森综合征中的细胞毒性T细胞过程) 的免疫疗法反应分析.
主要成果:
- 不同的临床表型,如 faciobrachial dystonic 发作 (LGI1脑炎) 和神经精神病呈现 (NMDA受体脑炎),与特定的抗体有关.
- 免疫疗法对针对细胞表面突触抗原的自身免疫脑类药物非常有效,但对细胞内抗原结合抗体或细胞毒性T细胞介导疾病 (如拉斯穆森综合征) 效果较差.
结论:
- 快速识别自身免疫性发作是免疫疗法有效治疗的关键.
- 自身免疫性脑,包括那些有副瘤病因和NORSE/FIRES等新兴综合征的脑,代表了的重要和可治疗的原因.
相关概念视频
Seizures: Classification
336
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
336
Autoimmune Disorders
417
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
417
Antiepileptic Drugs: Glutamate Antagonists
320
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
320
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
286
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
286
Arteries of the Lower Limbs
188
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
188
Antiepileptic Drugs: GABAergic Pathway Potentiators
385
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
385


